Results of Analysis of the OASIS Study,a Large-Scale Health-Related QOL Study in Patients with Chronic Cerebral Infarction
February 21, 2008
Having completed the OASIS Study, Japan's first large-scale study with respect to health-related quality of life (below, "health-related QOL") in Chronic Cerebral Infarction , Kyorin Pharmaceutical Co., Ltd. (Tokyo, President: Ikuo Ogihara), a subsidiary of Kyorin Co., Ltd., presented the study results at the International Stroke Conference 2008 at New Orleans, Louisiana, USA on February 20 local time.
Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.